Tag: Health Care

Vizient
United States

Vizient Surveys Impact of AI in Healthcare, Advancements in Pediatric Gene Therapy

IRVING, Texas – In its latest Pediatric Tech Watch, Vizient, Inc. surveys the impact of artificial intelligence (AI) in healthcare, advancements in pediatric gene therapy and rounds up the latest updates for pediatric immunizations. Read Pediatric Tech Watch. The unique needs of the pediatric population require specialized solutions. Post this “The unique needs of the pediatric population require specialized solutions,” said Sarah Herrmann, Vizient director of program services. … Continue reading Vizient Surveys Impact of AI in Healthcare, Advancements in Pediatric Gene Therapy

Impact Newswire
TruBridge
United States

TruBridge Elects Amy O’Keefe to the Company’s Board of Directors

New Director Brings Deep Financial and Operational Expertise October 21, 2024 – MOBILE, Ala.- TruBridge, Inc. (“TruBridge” or the “Company”) (NASDAQ:TBRG), a healthcare solutions company, today announced the election of Amy O’Keefe to its Board of Directors (the “Board”), effective October 18, 2024. “Amy’s deep financial experience and public company leadership spanning over three decades will be invaluable to TruBridge as we execute our growth … Continue reading TruBridge Elects Amy O’Keefe to the Company’s Board of Directors

Impact Newswire
enGene
United States

enGene Appoints Joan Connolly as Chief Technology Officer and Anthony Cheung, Ph.D., as Chief Scientific Officer

October 21, 2024 – BOSTON & MONTREAL – enGene Holdings Inc. (Nasdaq: ENGN or “enGene” or the “Company”), a clinical-stage genetic medicines company whose non-viral lead investigational product detalimogene voraplasmid (also known as detalimogene, and previously EG-70) is in an ongoing pivotal study in patients with high-risk, Bacillus Calmette-Guérin (BCG)-unresponsive, non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (Cis), today announced the appointment of … Continue reading enGene Appoints Joan Connolly as Chief Technology Officer and Anthony Cheung, Ph.D., as Chief Scientific Officer

Impact Newswire
Gruppo San Donato
Europe

Smart Clinic SpA is born: a joint venture between Gruppo San Donato, GKSD and Generali Italia for the health of the future 

The new company envisages the development of a network that will include a hundred structures by 2030 and will be chaired by Vito Cozzoli and led by CEO Bonifacio Moroni Press Release – The closing of the strategic agreement between San Donato Group, GKSD e Generali Italy: born Smart Clinic SpA, The company joint venture which aims to create, by 2030, a network of approximately 100 healthcare facilities across the entire Italian territory. … Continue reading Smart Clinic SpA is born: a joint venture between Gruppo San Donato, GKSD and Generali Italia for the health of the future 

Impact Newswire
Alpha Cognition
Global

Alpha Cognition Announces Appointment of VP Finance and Accounting

October 21, 2024 – VANCOUVER, British Columbia – Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF)(“Alpha Cognition” or the “Company”), a biopharmaceutical company committed to developing novel therapies for debilitating neurodegenerative disorders, announces that Henry Du has joined Alpha Cognition as the VP of Finance and Accounting and interim Chief Financial Officer (CFO). “I am excited to join Alpha Cognition at such a critical juncture” Post … Continue reading Alpha Cognition Announces Appointment of VP Finance and Accounting

Impact Newswire
Vianautis
Untied Kingdom

ViaNautis Bio appoints Dr Adi Hoess as Chief Executive Officer

ViaNautis Bio (“ViaNautis” or the “Company”), a groundbreaking nanomedicine company at the forefront of genetic therapies, today announces the appointment of Dr Adi Hoess as Chief Executive Officer of ViaNautis. He will succeed Co-Founder and CEO Dr Francesca Crawford who has been stepping down from her role. Dr Adi Hoess brings a wealth of experience to ViaNautis, having previously served as CEO of Nasdaq-listed German … Continue reading ViaNautis Bio appoints Dr Adi Hoess as Chief Executive Officer

Impact Newswire
CVS Health
United States

CVS Health Appoints David Joyner President and Chief Executive Officer

October 18, 2024 Roger Farah Named Executive Chairman of the Board Company provides preliminary guidance for third quarter 2024 GAAP diluted Earnings per Share (EPS) of $0.03 to $0.08 and Adjusted EPS of $1.05 to $1.10 WOONSOCKET, RI (October 18, 2024) – CVS Health (NYSE: CVS) today announced that David Joyner was appointed President and Chief Executive Officer, effective October 17, replacing Karen Lynch, who stepped … Continue reading CVS Health Appoints David Joyner President and Chief Executive Officer

Impact Newswire
Seaport Therapeutics
United States

Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round

Financing led by General Atlantic with participation from T. Rowe Price Associates, Foresite Capital, Invus, Goldman Sachs Alternatives, Canada Pension Plan Investment Board (CPP Investments) as well as other new investors Founding investors ARCH Venture Partners, Sofinnova Investments, Third Rock Ventures, and PureTech Health also participated Proceeds will support key clinical milestones in Seaport’s pipeline of first and best-in-class neuropsychiatric medicines BOSTON, October 21, 2024 … Continue reading Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round

Impact Newswire